Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1/placental growth factor ratio: An inter-assay comparison

Journal of the American Society of Hypertension

Volumn 9, Issue 2, 2015, Pages 86-96

  Andersen, Louise Bjørkholt ^a,b   Frederiksen Møller, Britta ^a,b   Work Havelund, Kathrine ^b   Dechend, Ralf ^c,d   Jørgensen, Jan Stener ^a,b   Jensen, Boye L ^e   Nielsen, Jan ^a   Lykkedegn, Sine ^a,b   Barington, Torben ^a   Christesen, Henrik Thybo ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d HELIOS Klinikum Berlin   (Germany)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

HELLP syndrome; Hypertension; obesity; pregnancy

Indexed keywords

FMS LIKE TYROSINE KINASE 1; PLACENTAL GROWTH FACTOR; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; PLACENTA PROTEIN; VASCULOTROPIN RECEPTOR 1;

ABDOMINAL CIRCUMFERENCE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HELLP SYNDROME; HEMOLYSIS; HUMAN; IMMUNOASSAY; IMMUNOASSAY ANALYZER; KRYPTOR ASSAY; PLACENTA WEIGHT; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SMALL FOR DATE INFANT; ADULT; BLOOD; COMPARATIVE STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; LUMINESCENCE; MALE; NEWBORN; PRE-ECLAMPSIA; PREGNANCY; PROCEDURES; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

ADULT; BIOMARKERS; EARLY DIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; LUMINESCENT MEASUREMENTS; MALE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84924610195     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2014.11.008     Document Type: Article

References (34)

1. B. Sibai, G. Dekker, and M. Kupferminc Pre-eclampsia Lancet 365 2005 785 799
2. ACOG practice bulletin Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists Obstet Gynecol 77 2002 67 75
3. E.A. Steegers, P. von Dadelszen, J.J. Duvekot, and R. Pijnenborg Pre-eclampsia Lancet 376 2010 631 644
4. J.M. Roberts, G.D. Pearson, J.A. Cutler, and M.D. Lindheimer Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy Hypertens Pregnancy 22 2003 109 127
5. A.C. Staff, S.J. Benton, P. von Dadelszen, J.M. Roberts, R.N. Taylor, and R.W. Powers Redefining preeclampsia using placenta-derived biomarkers Hypertension 61 2013 932 942
6. R.J. Levine, S.E. Maynard, C. Qian, K.H. Lim, L.J. England, and K.F. Yu Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683
7. C.E. Powe, R.J. Levine, and S.A. Karumanchi Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease Circulation 123 2011 2856 2869
8. S.E. Maynard, J.Y. Min, and J. Merchan Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
9. J.E. Park, H.H. Chen, J. Winer, K.A. Houck, and N. Ferrara Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR J Biol Chem 269 1994 25646 25654
10. P. Carmeliet, L. Moons, A. Luttun, V. Vincenti, V. Compernolle, and M. De Mol Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions Nat Med 7 2001 575 583
11. R. Thadhani, W.P. Mutter, M. Wolf, R.J. Levine, R.N. Taylor, and V.P. Sukhatme First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia J Clin Endocrinol Metab 89 2004 770 775
12. S. Verlohren, A. Galindo, D. Schlembach, H. Zeisler, I. Herraiz, and M.G. Moertl An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia Am J Obstet Gynecol 202 2010 161.e1 161.e11
13. A. Leanos-Miranda, I. Campos-Galicia, K.L. Ramirez-Valenzuela, Z.L. Chinolla-Arellano, and I. Isordia-Salas Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia Hypertension 61 2013 1118 1125
14. S.J. Benton, Y. Hu, F. Xie, K. Kupfer, S.W. Lee, and L.A. Magee Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays Am J Obstet Gynecol 205 2011 469.e1 469.e8
15. S. Verlohren, I. Herraiz, O. Lapaire, D. Schlembach, H. Zeisler, and P. Calda New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia Hypertension 63 2014 346 352
16. T.F. McElrath, K.H. Lim, E. Pare, J. Rich-Edwards, D. Pucci, and R. Troisi Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy Am J Obstet Gynecol 207 2012 407.e1 407.e7
17. S. Rana, S.A. Karumanchi, and M.D. Lindheimer Angiogenic factors in diagnosis, management, and research in preeclampsia Hypertension 63 2014 198 202
18. M. Wolf, A. Shah, C. Lam, A. Martinez, K.V. Smirnakis, and F.H. Epstein Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies Am J Obstet Gynecol 193 2005 16 22
19. C.A. Zera, E.W. Seely, L.E. Wilkins-Haug, K.H. Lim, S.I. Parry, and T.F. McElrath The association of body mass index with serum angiogenic markers in normal and abnormal pregnancies Am J Obstet Gynecol 211 2014 247.e1 247.e7
20. S. Rana, W.T. Schnettler, C. Powe, J. Wenger, S. Salahuddin, and A.S. Cerdeira Clinical characterization and outcomes of preeclampsia with normal angiogenic profile Hypertens Pregnancy 32 2013 189 201
21. E. Schneider, A. Gleixner, R. Hänel, Y. Leyhe, C. Kleinschmidt, and G. Beck Technical performance of the first fully automated assays for human soluble fms-like tyrosine kinase 1 and human placental growth factor Z Geburtshilfe Neonatol 213 2009 A8
22. L.B. Andersen, B. Abrahamsen, C. Dalgard, H.B. Kyhl, S.S. Beck-Nielsen, and M. Frost-Nielsen Parity and tanned white skin as novel predictors of vitamin D status in early pregnancy: a population-based cohort study Clin Endocrinol (Oxf) 79 2013 333 341
23. G. Mathis Rare earth cryptates and homogeneous fluoroimmunoassays with human sera Clin Chem 39 1993 1953 1959
24. K. Marsal, P.H. Persson, T. Larsen, H. Lilja, A. Selbing, and B. Sultan Intrauterine growth curves based on ultrasonically estimated foetal weights Acta Paediatr 85 1996 843 848
25. J.M. Bland, and D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 1986 307 310
26. L.I. Lin A concordance correlation coefficient to evaluate reproducibility Biometrics 45 1989 255 268
27. S. Rana, C.E. Powe, S. Salahuddin, S. Verlohren, F.H. Perschel, and R.J. Levine Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia Circulation 125 2012 911 919
28. S. Rana, M.R. Hacker, A.M. Modest, S. Salahuddin, K.H. Lim, and S. Verlohren Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia Hypertension 60 2012 451 458
29. H. Lehnen, N. Mosblech, T. Reineke, A. Puchooa, I. Menke-Möllers, and U. Zechner Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsia, Pregnancy-induced Hypertension, and Proteinuria Geburtshilfe Frauenheilkd 73 2013 440 445
30. S. Rana, and S.A. Karumanchi Response to Carbillon L et al. letter titled, "The imbalance of circulating angiogenic/anti-angiogenic factors is mild or absent in obese women destined to develop preeclampsia." Hypertens Pregnancy 33 2014 525
31. S. Bae, B. Yalamarti, Q. Ke, S. Choudhury, H. Yu, and S.A. Karumanchi Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats Cardiovasc Res 91 2011 632 639
32. M. Nucci, L.C. Poon, G. Demirdjian, B. Darbouret, and K.H. Nicolaides Maternal serum placental growth factor isoforms 1 and 2 at 11-13, 20-24 and 30-34 weeks' gestation in late-onset pre-eclampsia and small for gestational age neonates Fetal Diagn Ther 35 2014 249 257
33. M. Nucci, L.C. Poon, G. Demirdjian, B. Darbouret, and K.H. Nicolaides Maternal Serum Placental Growth Factor (PlGF) Isoforms 1 and 2 at 11-13 Weeks' Gestation in Normal and Pathological Pregnancies Fetal Diagn Ther 36 2014 106 116
34. L. Myatt, C.W. Redman, A.C. Staff, S. Hansson, M.L. Wilson, and H. Laivuori Strategy for standardization of preeclampsia research study design Hypertension 63 2014 1293 1301